Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000401 · ClinicalTrials.gov registry record · Phase 2
Oral Collagen for Rheumatoid Arthritis
A Phase 2 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00000401 is a Phase 2 study that has completed, run by University of Tennessee. The registered enrollment target is 110 participants.
The verdict
NCT00000401, a Phase 2 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by swelling and inflammation of the joints. In RA, the immune system attacks a person's own cells inside joints, eventually leading to joint damage and disability. This study will determine if oral bovine type II collagen (bovine CII) will lead to decreased joint inflammation in RA patients.
Interventions
- DRUG Oral bovine type II collagen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 1999-07 |
| Est. Completion | 2005-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000401
The ClinicalTrials.gov registry entry for NCT00000401 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral bovine type II collagen is the first listed.
NCT00000401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000401 about?
NCT00000401 is a clinical study titled "Oral Collagen for Rheumatoid Arthritis". Rheumatoid arthritis (RA) is an autoimmune disease characterized by swelling and inflammation of the joints. In RA, the immune system attacks a person's own cells inside joints, eventually leading to joint damage and disability. This study will determine if oral bovine type II collagen (bovine CII) ...
What is the current status of trial NCT00000401?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 1999-07. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00000401?
The interventions under investigation include: Oral bovine type II collagen (DRUG).
Who is sponsoring clinical trial NCT00000401?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.